Literature DB >> 11779927

Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events.

Herwig W Schuchlenz1, Wolfgang Weihs, Albrecht Beitzke, Jörg-Ingolf Stein, Andreas Gamillscheg, Peter Rehak.   

Abstract

BACKGROUND AND
PURPOSE: Patent foramen ovale (PFO) is a risk factor for paradoxical embolism, and severe shunting and wide opening of PFO are risk factors for severe and recurrent cerebrovascular events. Neither contrast echocardiography nor 2-dimensional (2D) measurement of PFO size have been validated or compared with invasive balloon sizing.
METHODS: We performed transesophageal echocardiography (TEE) in 100 patients with cryptogenic stroke and catheter closure of PFO. The amount of contrast shunting through the PFO during cubital and femoral contrast delivery and the PFO size measured by 2D TEE were compared with balloon sizing.
RESULTS: There was a significant correlation (r(2)=0.8; P<0.0001) between 2D TEE measurement and invasive balloon sizing. Mean balloon-sized PFO diameter was significantly larger than mean PFO diameter measured by 2D TEE (8.3+/-2.6 versus 5.2+/-1.7 mm). Semiquantitative contrast TEE correlated with PFO size (r(2)=0.7; P<0.0001) only if the contrast agent was administered through a femoral vein. Correlation was poor when the contrast agent was administered via a cubital vein.
CONCLUSIONS: We conclude that 2D TEE measurement of a PFO size is more accurate than the traditionally used contrast technique.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779927     DOI: 10.1161/hs0102.100883

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

Review 1.  Indications for the closure of patent foramen ovale.

Authors:  Michael J Landzberg; Paul Khairy
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  When and how to diagnose patent foramen ovale.

Authors:  F J Pinto
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  The role of the sizing balloon in selection of the patent foramen ovale closure device size.

Authors:  J Alibegovic; Rf Bonvini; U Sigwart; Pa Dorsaz; E Camenzind; V Verin
Journal:  Exp Clin Cardiol       Date:  2008

4.  The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.

Authors:  Benjamin S Wessler; David M Kent; David E Thaler; Robin Ruthazer; Jennifer S Lutz; Joaquín Serena
Journal:  Cerebrovasc Dis       Date:  2015-07-11       Impact factor: 2.762

5.  Detecting Patent Foramen Ovale after Cryptogenic Stroke - A Single Center Experience in Taiwan.

Authors:  Ting-Yu Lin; Yun-Ching Fu; Sheng-Ling Jan; Ming-Chih Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

6.  Prevalence of patent foramen ovale in a consecutive cohort of 261 patients undergoing routine "coronary" 64-multi-detector cardiac computed tomography.

Authors:  John A Purvis; David R Morgan; Sinead M Hughes
Journal:  Ulster Med J       Date:  2011-05

7.  Correlation between Patent Foramen Ovale, Cerebral "Lesions" and Neuropsychometric Testing in Experienced Sports Divers: Does Diving Damage the Brain?

Authors:  Costantino Balestra; Peter Germonpré
Journal:  Front Psychol       Date:  2016-05-11

Review 8.  Patent foramen ovale and atrial fibrillation as causes of cryptogenic stroke: is treatment with surgery superior to device closure and anticoagulation? A review of the literature.

Authors:  Thomas Kjeld; Tem S Jørgensen; Gitte Fornitz; Jan Roland; Henrik C Arendrup
Journal:  Acta Radiol Open       Date:  2018-08-23

9.  Microembolic signal detection by transcranial Doppler: Old method with a new indication.

Authors:  Sombat Muengtaweepongsa; Charturong Tantibundhit
Journal:  World J Methodol       Date:  2018-11-29

10.  Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age.

Authors:  Holger Poppert; Melanie Morschhaeuser; Regina Feurer; Angelina Bockelbrink; Jens Schwarze; Lorena Esposito; Peter Heider; Dirk Sander; Bernhard Hemmer
Journal:  J Negat Results Biomed       Date:  2008-10-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.